These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6852097)

  • 21. Continuous telemetry from a chronic canine model of sudden cardiac death.
    Killingsworth CR; Ritscher DE; Walcott GP; Rollins DL; Ideker RE; Smith WM
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1333-41. PubMed ID: 11196555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The circumflex coronary artery occlusion canine model of sudden death: methodology and electrocardiographic observations.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Serradimigni A
    J Electrocardiol; 1986 Apr; 19(2):155-64. PubMed ID: 3711753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
    Patterson E; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Aug; 230(2):519-26. PubMed ID: 6086892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E; Amalfitano DJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.
    Friedrichs GS; Abreu JN; Black SC; Chi L; Lucchesi BR
    Eur J Pharmacol; 1996 Jun; 306(1-3):99-106. PubMed ID: 8813621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model.
    Wilber DJ; Lynch JJ; Montgomery D; Lucchesi BR
    Am Heart J; 1985 Jan; 109(1):8-18. PubMed ID: 3966335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
    Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR
    Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog.
    Jouve R; Langlet F; Puddu PE; Rolland PH; Guillen JC; Cano JP; Serradimigni A
    J Cardiovasc Pharmacol; 1986; 8(1):208-15. PubMed ID: 2419686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death.
    Kou WH; Nelson SD; Lynch JJ; Montgomery DG; DiCarlo L; Lucchesi BR
    J Am Coll Cardiol; 1987 Feb; 9(2):359-65. PubMed ID: 3100599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effects of HOE642, a novel Na(+)-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts.
    Xue YX; Aye NN; Hashimoto K
    Eur J Pharmacol; 1996 Dec; 317(2-3):309-16. PubMed ID: 8997615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
    Chi LG; Mu DX; Lucchesi BR
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmogenic effects of graded coronary blood flow reductions superimposed on prior myocardial infarction in dogs.
    Furukawa T; Moroe K; Mayrovitz HN; Sampsell R; Furukawa N; Myerburg RJ
    Circulation; 1991 Jul; 84(1):368-77. PubMed ID: 2060107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction.
    Garan H; McComb JM; Ruskin JN
    J Am Coll Cardiol; 1988 Mar; 11(3):603-11. PubMed ID: 3343465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST segment changes in the canine heart.
    Kniffen FJ; Lomas TE; Burmeister WE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jul; 194(1):234-43. PubMed ID: 1151752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM; Patterson E; Pitt B; Lucchesi B
    Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs.
    Patterson E; Stetson P; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):449-53. PubMed ID: 7391989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.
    Benfey BG; Elfellah MS; Ogilvie RI; Varma DR
    Br J Pharmacol; 1984 Jul; 82(3):717-25. PubMed ID: 6743921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
    J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.